{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:49:59Z","timestamp":1778165399044,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jfma.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T17:24:40Z","timestamp":1739640280000},"page":"415-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prediction of clinically significant prostate cancer using extra-transitional zone prostate-specific antigen among Taiwanese men"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2437-9782","authenticated-orcid":false,"given":"Jung-Yang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-0695","authenticated-orcid":false,"given":"Shin-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chieh","family":"Jeff Chueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-5315","authenticated-orcid":false,"given":"Chung-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong-Shiau","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jfma.2025.02.002_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"9959","key":"10.1016\/j.jfma.2025.02.002_bib2","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European randomised study of screening for prostate cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schroder","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jfma.2025.02.002_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa1201637","article-title":"Quality-of-life effects of prostate-specific antigen screening","volume":"367","author":"Heijnsdijk","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jfma.2025.02.002_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"issue":"18","key":"10.1016\/j.jfma.2025.02.002_bib5","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US preventive services task force","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jfma.2025.02.002_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0094-0143(05)70374-8","article-title":"The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration","volume":"24","author":"Tchetgen","year":"1997","journal-title":"Urol Clin"},{"issue":"2 Pt 1","key":"10.1016\/j.jfma.2025.02.002_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","article-title":"Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels","volume":"154","author":"Nadler","year":"1995","journal-title":"J Urol"},{"issue":"13","key":"10.1016\/j.jfma.2025.02.002_bib8","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jfma.2025.02.002_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-156-8-201204170-00010","article-title":"National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer","volume":"156","author":"Ganz","year":"2012","journal-title":"Ann Intern Med"},{"issue":"3 Pt 2","key":"10.1016\/j.jfma.2025.02.002_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","article-title":"Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer","volume":"147","author":"Benson","year":"1992","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.002_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41391-017-0024-7","article-title":"Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer","volume":"21","author":"Nordstrom","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.02.002_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0090-4295(94)90170-8","article-title":"Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate","volume":"43","author":"Kalish","year":"1994","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.jfma.2025.02.002_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.12954\/PI.13022","article-title":"Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5 alpha-reductase inhibitors","volume":"1","author":"Koo","year":"2013","journal-title":"Prostate Int"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.002_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(20000815)89:4<842::AID-CNCR17>3.0.CO;2-9","article-title":"Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma","volume":"89","author":"Kikuchi","year":"2000","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jfma.2025.02.002_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1442-2042.1999.00089.x","article-title":"Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer","volume":"6","author":"Moon","year":"1999","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.002_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1590\/s1677-5538.ibju.2017.0506","article-title":"Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng\/mL","volume":"44","author":"Castro","year":"2018","journal-title":"Int Braz J Urol"},{"issue":"3","key":"10.1016\/j.jfma.2025.02.002_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/andr.12322","article-title":"The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng\/mL","volume":"5","author":"Shen","year":"2017","journal-title":"Andrology"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.002_bib18","first-page":"332","article-title":"The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men <\/= 50 years","volume":"2","author":"Kosaka","year":"2014","journal-title":"Am J Clin Exp Urol"},{"issue":"12","key":"10.1016\/j.jfma.2025.02.002_bib19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","article-title":"Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread","volume":"12","author":"McNeal","year":"1988","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.002_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41598-018-36602-x","article-title":"Establishment and validation of extra-transitional zone prostate specific antigen density (ETzD), a novel structure-based parameter for quantifying the oncological hazard of prostates with enlarged stroma","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.002_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12885-021-08216-6","article-title":"Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?","volume":"21","author":"Lee","year":"2021","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.jfma.2025.02.002_bib22","first-page":"1288","article-title":"NCCN guidelines(R) insights: prostate cancer, version 1.2023","volume":"20","author":"Schaeffer","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jfma.2025.02.002_bib23","unstructured":"Network NCC. Prostate cancer (Version 2.2022) [Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf."},{"issue":"23","key":"10.1016\/j.jfma.2025.02.002_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235932","article-title":"The role and significance of bioumoral markers in prostate cancer","volume":"13","author":"Constantin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.002_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/JU.0000000000000757","article-title":"Predictive factors of missed clinically significant prostate cancers in men with negative magnetic resonance imaging: a systematic review and meta-analysis","volume":"204","author":"Pagniez","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.002_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12894-020-00717-z","article-title":"Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng\/ml","volume":"20","author":"Chang","year":"2020","journal-title":"BMC Urol"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.002_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/aja202218","article-title":"New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study","volume":"25","author":"Huang","year":"2023","journal-title":"Asian J Androl"},{"issue":"19","key":"10.1016\/j.jfma.2025.02.002_bib28","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.002_bib29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.euf.2017.11.010","article-title":"Prostate magnetic resonance imaging interpretation varies substantially across radiologists","volume":"5","author":"Sonn","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.002_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2020190646","article-title":"Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease-focused panel","volume":"296","author":"Westphalen","year":"2020","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jfma.2025.02.002_bib31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00345-020-03397-4","article-title":"The predictive value of the prostate health index vs. multiparametric magnetic resonance imaging for prostate cancer diagnosis in prostate biopsy","volume":"39","author":"Stejskal","year":"2021","journal-title":"World J Urol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:34:49Z","timestamp":1773758089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0929664625000440"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.02.002","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of clinically significant prostate cancer using extra-transitional zone prostate-specific antigen among Taiwanese men","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2026, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}